Syndax Pharmaceuticals Inc (SNDX)
20.08
-0.58
(-2.81%)
USD |
NASDAQ |
Jul 03, 16:00
Syndax Pharmaceuticals Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 3.407M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 1.393M |
| December 31, 2022 | 3.474M |
| Date | Value |
|---|---|
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2021
3.474M
Maximum
Dec 2022
1.379M
Average
0.6965M
Median
Accounts Receivable (Quarterly) Benchmarks
| Agios Pharmaceuticals Inc | 3.453M |
| Krystal Biotech Inc | 46.47M |
| Crinetics Pharmaceuticals Inc | -- |
| Arvinas Inc | -- |
| BridgeBio Pharma Inc | -- |